Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2008 2
2009 3
2010 1
2011 1
2012 4
2013 1
2014 4
2015 3
2016 4
2017 1
2018 5
2019 10
2020 2
2021 5
2022 4
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. Simpson EL, et al. N Engl J Med. 2016 Dec 15;375(24):2335-2348. doi: 10.1056/NEJMoa1610020. Epub 2016 Sep 30. N Engl J Med. 2016. PMID: 27690741 Free article. Clinical Trial.
Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.
Bieber T, Simpson EL, Silverberg JI, Thaçi D, Paul C, Pink AE, Kataoka Y, Chu CY, DiBonaventura M, Rojo R, Antinew J, Ionita I, Sinclair R, Forman S, Zdybski J, Biswas P, Malhotra B, Zhang F, Valdez H; JADE COMPARE Investigators. Bieber T, et al. N Engl J Med. 2021 Mar 25;384(12):1101-1112. doi: 10.1056/NEJMoa2019380. N Engl J Med. 2021. PMID: 33761207 Clinical Trial.
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Silverberg JI, Guttman-Yassky E, Thaçi D, Irvine AD, Stein Gold L, Blauvelt A, Simpson EL, Chu CY, Liu Z, Gontijo Lima R, Pillai SG, Seneschal J; ADvocate1 and ADvocate2 Investigators. Silverberg JI, et al. N Engl J Med. 2023 Mar 23;388(12):1080-1091. doi: 10.1056/NEJMoa2206714. Epub 2023 Mar 15. N Engl J Med. 2023. PMID: 36920778 Clinical Trial.
Consensus Update for Systemic Treatment of Atopic Dermatitis.
Lee JH, Kim JE, Park GH, Bae JM, Byun JY, Shin MK, Han TY, Hong SP, Jang YH, Kim HO, Na CH, Lew BL, Ahn J, Park CO, Seo YJ, Lee YW, Son SW, Choi EH, Park YL, Roh JY. Lee JH, et al. Among authors: park yl. Ann Dermatol. 2021 Dec;33(6):497-514. doi: 10.5021/ad.2021.33.6.497. Epub 2021 Nov 4. Ann Dermatol. 2021. PMID: 34858001 Free PMC article.
Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea.
Lee DH, Ko HC, Na CH, Roh JY, Park KY, Park YL, Park YM, Park CO, Park CW, Bae Y, Seo YJ, Son SW, Ahn J, Jung HJ, Yang JM, Won CH, Yoo KH, Lew BL, Lee SE, Lee SY, Lee SC, Lee YW, Lee JH, Jang YH, Jeon J, Han TY, Cho SH. Lee DH, et al. Among authors: park yl. Ann Dermatol. 2022 Apr;34(2):157-160. doi: 10.5021/ad.2022.34.2.157. Epub 2022 Mar 24. Ann Dermatol. 2022. PMID: 35450314 Free PMC article. No abstract available.
Childhood granulomatous periorificial dermatitis.
Kim YJ, Shin JW, Lee JS, Park YL, Whang KU, Lee SY. Kim YJ, et al. Among authors: park yl. Ann Dermatol. 2011 Aug;23(3):386-8. doi: 10.5021/ad.2011.23.3.386. Epub 2011 Aug 6. Ann Dermatol. 2011. PMID: 21909215 Free PMC article.
56 results